FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078541569> ?p ?o ?g. }

• W2078541569 endingPage "374" @default.
• W2078541569 startingPage "368" @default.
• W2078541569 abstract "All trans-retinoic acid (ATRA) induces apoptosis and/or differentiation in solid tumors, including breast cancer, and has become a therapeutic tool in this disease. In human promyelocytic leukemia ATRA reduces the expression of cellular procoagulant activities (PCA), i.e. tissue factor (TF) and cancer procoagulant (CP). There are no studies on the effects of ATRA on the PCA of solid tumors, i.e. breast cancer cells. We analyzed different human breast cancer cell lines in order to: 1. characterize the expression of TF and CP; 2. evaluate whether these activities are affected by ATRA; and 3. verify whether a reduction in tumor cell procoagulants may occur in association to apoptosis and growth inhibition induced by ATRA. Two estrogen receptor positive (ER-positive; i.e. MCF7 and ZR75.1) and one estrogen receptor negative (ER-negative; i.e. MDA.MB.231) cell lines were included into the study. The results show that ATRA affected TF in a dose-dependent fashion only in ER-positive cell lines. In particular, at 1 uM ATRA, TF significantly (p < 0.05) decreased by 57%, 44% in MCF7, ZR75.1 cells, respectively. Differently the results show that ATRA dose-dependently affected CP expression in all three cell lines. Specifically, at 1 uM ATRA, CP significantly decreased by 44%, 50% and 25% in MCF7, ZR75.1, and MDA.MB.231. Only in ER-positive cell lines, there was a dose-dependent inhibition of cell growth that became statistically significant at 1 uM ATRA, which was associated to a slight but significant increase in the percentage of apoptotic cells. In conclusion, this study demonstrates for the first time that ATRA downregulates the expression of TF and CP in breast cancer cells. Due to the pivotal role of coagulation activation in tumor progression, the capacity of ATRA to affect also tumor procoagulants, in parallel to cell apoptosis, open new perspectives in tumor therapy." @default.
• W2078541569 created "2016-06-24" @default.
• W2078541569 creator A5039927165 @default.
• W2078541569 creator A5058851458 @default.
• W2078541569 creator A5075340882 @default.
• W2078541569 creator A5087884641 @default.
• W2078541569 date "2011-10-01" @default.
• W2078541569 modified "2023-10-18" @default.
• W2078541569 title "All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells" @default.
• W2078541569 cites W1832657260 @default.
• W2078541569 cites W1901279264 @default.
• W2078541569 cites W1954910358 @default.
• W2078541569 cites W1967331416 @default.
• W2078541569 cites W1971624992 @default.
• W2078541569 cites W1984352482 @default.
• W2078541569 cites W1999668293 @default.
• W2078541569 cites W2016739032 @default.
• W2078541569 cites W2037810958 @default.
• W2078541569 cites W2038528529 @default.
• W2078541569 cites W2048006697 @default.
• W2078541569 cites W2065336608 @default.
• W2078541569 cites W2075829745 @default.
• W2078541569 cites W2083126720 @default.
• W2078541569 cites W2090711973 @default.
• W2078541569 cites W2100184560 @default.
• W2078541569 cites W2121594719 @default.
• W2078541569 cites W2149062346 @default.
• W2078541569 cites W2152026566 @default.
• W2078541569 cites W2152800241 @default.
• W2078541569 cites W2155066067 @default.
• W2078541569 cites W2155647570 @default.
• W2078541569 cites W2169375165 @default.
• W2078541569 cites W2285082870 @default.
• W2078541569 cites W2328710175 @default.
• W2078541569 cites W2343220138 @default.
• W2078541569 cites W2465203024 @default.
• W2078541569 cites W2490019007 @default.
• W2078541569 cites W4230033805 @default.
• W2078541569 doi "https://doi.org/10.1016/j.thromres.2011.03.006" @default.
• W2078541569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21458031" @default.
• W2078541569 hasPublicationYear "2011" @default.
• W2078541569 type Work @default.
• W2078541569 sameAs 2078541569 @default.
• W2078541569 citedByCount "14" @default.
• W2078541569 countsByYear W20785415692012 @default.
• W2078541569 countsByYear W20785415692013 @default.
• W2078541569 countsByYear W20785415692014 @default.
• W2078541569 countsByYear W20785415692015 @default.
• W2078541569 countsByYear W20785415692016 @default.
• W2078541569 countsByYear W20785415692017 @default.
• W2078541569 countsByYear W20785415692019 @default.
• W2078541569 countsByYear W20785415692022 @default.
• W2078541569 crossrefType "journal-article" @default.
• W2078541569 hasAuthorship W2078541569A5039927165 @default.
• W2078541569 hasAuthorship W2078541569A5058851458 @default.
• W2078541569 hasAuthorship W2078541569A5075340882 @default.
• W2078541569 hasAuthorship W2078541569A5087884641 @default.
• W2078541569 hasConcept C121608353 @default.
• W2078541569 hasConcept C126322002 @default.
• W2078541569 hasConcept C134018914 @default.
• W2078541569 hasConcept C185592680 @default.
• W2078541569 hasConcept C186738567 @default.
• W2078541569 hasConcept C190283241 @default.
• W2078541569 hasConcept C2776601000 @default.
• W2078541569 hasConcept C2778382381 @default.
• W2078541569 hasConcept C2779707156 @default.
• W2078541569 hasConcept C2779963572 @default.
• W2078541569 hasConcept C2781121885 @default.
• W2078541569 hasConcept C502942594 @default.
• W2078541569 hasConcept C530470458 @default.
• W2078541569 hasConcept C54355233 @default.
• W2078541569 hasConcept C55493867 @default.
• W2078541569 hasConcept C62112901 @default.
• W2078541569 hasConcept C71924100 @default.
• W2078541569 hasConcept C81885089 @default.
• W2078541569 hasConcept C84606932 @default.
• W2078541569 hasConcept C86803240 @default.
• W2078541569 hasConcept C96232424 @default.
• W2078541569 hasConceptScore W2078541569C121608353 @default.
• W2078541569 hasConceptScore W2078541569C126322002 @default.
• W2078541569 hasConceptScore W2078541569C134018914 @default.
• W2078541569 hasConceptScore W2078541569C185592680 @default.
• W2078541569 hasConceptScore W2078541569C186738567 @default.
• W2078541569 hasConceptScore W2078541569C190283241 @default.
• W2078541569 hasConceptScore W2078541569C2776601000 @default.
• W2078541569 hasConceptScore W2078541569C2778382381 @default.
• W2078541569 hasConceptScore W2078541569C2779707156 @default.
• W2078541569 hasConceptScore W2078541569C2779963572 @default.
• W2078541569 hasConceptScore W2078541569C2781121885 @default.
• W2078541569 hasConceptScore W2078541569C502942594 @default.
• W2078541569 hasConceptScore W2078541569C530470458 @default.
• W2078541569 hasConceptScore W2078541569C54355233 @default.
• W2078541569 hasConceptScore W2078541569C55493867 @default.
• W2078541569 hasConceptScore W2078541569C62112901 @default.
• W2078541569 hasConceptScore W2078541569C71924100 @default.
• W2078541569 hasConceptScore W2078541569C81885089 @default.
• W2078541569 hasConceptScore W2078541569C84606932 @default.
• W2078541569 hasConceptScore W2078541569C86803240 @default.

• next